Cargando…
Osteocyte Egln1/Phd2 links oxygen sensing and biomineralization via FGF23
Osteocytes act within a hypoxic environment to control key steps in bone formation. FGF23, a critical phosphate-regulating hormone, is stimulated by low oxygen/iron in acute and chronic diseases, however the molecular mechanisms directing this process remain unclear. Our goal was to identify the ost...
Autores principales: | Noonan, Megan L., Ni, Pu, Solis, Emmanuel, Marambio, Yamil G., Agoro, Rafiou, Chu, Xiaona, Wang, Yue, Gao, Hongyu, Xuei, Xiaoling, Clinkenbeard, Erica L., Jiang, Guanglong, Liu, Sheng, Stegen, Steve, Carmeliet, Geert, Thompson, William R., Liu, Yunlong, Wan, Jun, White, Kenneth E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845350/ https://www.ncbi.nlm.nih.gov/pubmed/36650133 http://dx.doi.org/10.1038/s41413-022-00241-w |
Ejemplares similares
-
Osteocytic FGF23 and Its Kidney Function
por: Agoro, Rafiou, et al.
Publicado: (2020) -
Erythropoietin and a hypoxia‐inducible factor prolyl hydroxylase inhibitor (HIF‐PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
por: Noonan, Megan L., et al.
Publicado: (2020) -
Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin
por: Stegen, Steve, et al.
Publicado: (2018) -
Single cell cortical bone transcriptomics define novel osteolineage gene sets altered in chronic kidney disease
por: Agoro, Rafiou, et al.
Publicado: (2023) -
Segregating the effects of ferric citrate‐mediated iron utilization and FGF23 in a mouse model of CKD
por: Liesen, Michael P., et al.
Publicado: (2022)